Pfizer (United States)
In research, Pfizer (United States) stands highest in Health Sciences (#315 of 9,902 worldwide), Medicine (#314 of 8,541 worldwide) and Life Sciences (#574 of 6,403 worldwide), 2022-now. Relative to its size it is most specialised in Applied Microbiology and Biotechnology, Statistics and Probability and Hematology (Applied Microbiology and Biotechnology is 12.9× its share of world research).
- World rank, 2022-now
- #644 of 22,385 · #644 all time
- Rank in United States
- #162 of 3,332
- Research works
- 26k ▲ 14% vs 2018-21
- Citations
- 981k 38.4 per fractional work
- Top-10% rate
- 15.4% all institutions 10.0%
- vs its own fields
- 1.32× 1.00× is exactly expected
- Open access
- 34% world 40%
- International
- 26% world 18%
What is Pfizer (United States) known for in research?
The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Health SciencesDomain | #315 of 9,902 | 16.5% | 1,581 | #270 | |
| MedicineField | #314 of 8,541 | 16.7% | 1,495 | #265 | |
| Life SciencesDomain | #574 of 6,403 | 16.4% | 697 | #419 | |
| Physical SciencesDomain | #1,004 of 10,670 | 13.6% | 400 | #1215 | |
| Infectious DiseasesSubfield | #43 of 421 | 26.2% | 144 | #121 | |
| Biochemistry, Genetics and Molecular BiologyField | #403 of 2,964 | 17.0% | 396 | #358 | |
| EpidemiologySubfield | #152 of 927 | 18.5% | 262 | #188 | |
| ChemistryField | #241 of 1,299 | 13.2% | 124 | #244 | |
| Molecular BiologySubfield | #376 of 1,880 | 18.1% | 236 | #321 | |
| Social SciencesDomain | #2,613 of 9,585 | 12.7% | 234 | #3071 |
Each strip is that field's whole ranked pool, with the notch where Pfizer (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Health Sciences#270 #315
- Medicine#265 #314
- Life Sciences#419 #574
- Physical Sciences#1,215 #1,004
- Infectious Diseases#121 #43
- Biochemistry, Genetics and Molecular Biology#358 #403
- Epidemiology#188 #152
- Chemistry#244 #241
- Molecular Biology#321 #376
- Social Sciences#3,071 #2,613
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
Which fields of science does Pfizer (United States) work in?
In 2022-now, 54% of research at Pfizer (United States) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (52%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (6%). It does 2.3× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 26 fields, with their numbers
- Health Sciences1,76754.3%
- Medicine1,67551.5%
- Health Professions752.3%
- Veterinary100.3%
- Nursing40.1%
- Dentistry20.1%
- Life Sciences78524.1%
- Physical Sciences44513.7%
- Chemistry1364.2%
- Engineering902.8%
- Mathematics812.5%
- Computer Science692.1%
- Environmental Science300.9%
- Materials Science280.9%
- Chemical Engineering40.1%
- Physics and Astronomy40.1%
- Energy20.1%
- Earth and Planetary Sciences10.0%
- Social Sciences2557.9%
- Economics, Econometrics and Finance1143.5%
- Social Sciences762.3%
- Psychology260.8%
- Decision Sciences210.6%
- Business, Management and Accounting140.4%
- Arts and Humanities40.1%
What does Pfizer (United States) specialise in?
Where its research is concentrated relative to its size: Applied Microbiology and Biotechnology takes 12.9× the share of its output that it takes of world research.
- Applied Microbiology and BiotechnologySubfield · 20.8 works13×
- Statistics and ProbabilitySubfield · 70.9 works10×
- HematologySubfield · 86.7 works8.8×
- Pharmaceutical ScienceSubfield · 27.3 works7.9×
- MicrobiologySubfield · 26.0 works7.7×
- Infectious DiseasesSubfield · 162.7 works7.4×
- ParasitologySubfield · 25.2 works7.3×
- PharmacologySubfield · 42.5 works7.0×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 7.0×. Every wedge is a field page.
All 26 fields, with their numbers
- Pharmacology, Toxicology and Pharmaceutics7.01×80 works
- Immunology and Microbiology6.02×197 works
- Medicine2.68×1,675 works
- Chemistry2.66×136 works
- Biochemistry, Genetics and Molecular Biology2.59×449 works
- Veterinary2.37×10 works
- Mathematics2.12×81 works
- Economics, Econometrics and Finance1.64×114 works
- Health Professions0.88×76 works
- Decision Sciences0.67×21 works
- Neuroscience0.48×25 works
- Chemical Engineering0.33×4 works
- Computer Science0.27×69 works
- Psychology0.26×26 works
- Materials Science0.25×28 works
- Nursing0.25×4 works
- Agricultural and Biological Sciences0.22×34 works
- Environmental Science0.19×30 works
- Engineering0.18×90 works
- Social Sciences0.18×76 works
- Business, Management and Accounting0.13×14 works
- Dentistry0.12×2 works
- Energy0.07×2 works
- Physics and Astronomy0.05×4 works
- Arts and Humanities0.05×4 works
- Earth and Planetary Sciences0.03×1 works
- Pharmacology, Toxicology and Pharmaceutics 7.0×
- Immunology and Microbiology 6.0×
- Medicine 2.7×
- Chemistry 2.7×
- Biochemistry, Genetics and Molecular Biology 2.6×
- Veterinary 2.4×
- Mathematics 2.1×
- Economics, Econometrics and Finance 1.6×
- Health Professions 0.9×
- Decision Sciences 0.7×
- Neuroscience 0.5×
- Chemical Engineering 0.3×
- Computer Science 0.3×
- Psychology 0.3×
- Materials Science 0.2×
- Nursing 0.2×
- Agricultural and Biological Sciences 0.2×
- Environmental Science 0.2×
- Engineering 0.2×
- Social Sciences 0.2×
- Business, Management and Accounting 0.1×
- Dentistry 0.1×
- Energy 0.1×
- Physics and Astronomy 0.1×
- Arts and Humanities 0.1×
- Earth and Planetary Sciences 0.0×
Who are the top researchers at Pfizer (United States)?
Ranked on the quality score, James G. Christensen, Xinmeng Jasmine Mu and Kena A. Swanson lead among researchers whose main affiliation is Pfizer (United States).
- 1
James G. Christensen
United States · #1,803 worldwide 47k citations · 997 works
- 2
Xinmeng Jasmine Mu
United States · #15,803 worldwide 35k citations · 136 works
- 3
Kena A. Swanson
United States · #16,982 worldwide 34k citations · 147 works
- 4
Cynthia Huang Bartlett
United States · #25,161 worldwide 12k citations · 124 works
- 5
Philip R. Dormitzer
United States · #25,195 worldwide 39k citations · 153 works
- 6
Eric B. Fauman
United States · #26,550 worldwide 12k citations · 119 works
- 7
Luis Jódar
United States · #29,553 worldwide 9.5k citations · 221 works
- 8
David A. Cooper
United States · #30,245 worldwide 33k citations · 121 works
- 9
Hans‐Peter Gerber
United States · #32,584 worldwide 28k citations · 240 works
- 10
Ronald Scott Obach
United States · #36,933 worldwide 25k citations · 302 works
Which keywords describe research at Pfizer (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Vaccine Development, SARS-CoV-2, Disease Burden, Viral Infections, Human Metapneumovirus, Respiratory Syncytial Virus and Vaccine.
- spike protein
- Therapeutic Antibodies
- Immunogenicity
- Health Utility Measures
- Economic Evaluation
- Breast Cancer
- Mutation
- Pneumococcal Conjugate Vaccine
- Vaccination
- Immunotherapy
- Chemotherapy
- Immunity
- ACE2 Receptor
- Quality of Life
- Respiratory Syncytial Virus
- Viral Infections
- Clinical Trials
- Clinical Practice Guidelines
- Vaccine Development
- Inflammation
- Epidemiology
- Pandemic
- SARS-CoV-2
- Pathogenesis
- Disease Burden
- Human Metapneumovirus
- Vaccine
- Antimicrobial Resistance
- Immune Response
- Biomarkers
- Monoclonal Antibodies
- Respiratory Infections
- Community-Acquired Pneumonia
- Pharmacokinetics
- Medicinal Chemistry
- Coronavirus
- Cost-effectiveness Analysis
- Biopharmaceuticals
- Viral Transmission
- antibody
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology563▲ 4.3×111 topics
- Inflammation157▲ 2.3×73 topics
- Pandemic140▲ 4.3×10 topics
- Vaccine Development127▲ 15×8 topics
- SARS-CoV-2120▲ 12×6 topics
- Clinical Practice Guidelines114▲ 6.4×14 topics
- Pathogenesis114▲ 6.8×20 topics
- Clinical Trials113▲ 5.2×17 topics
- Disease Burden113▲ 46×2 topics
- Viral Infections112▲ 60×2 topics
- Human Metapneumovirus111▲ 73×1 topic
- Respiratory Syncytial Virus111▲ 73×1 topic
- Vaccine110▲ 8.5×11 topics
- Quality of Life108▲ 2.3×40 topics
- Antimicrobial Resistance105▲ 16×9 topics
- ACE2 Receptor98▲ 13×3 topics
- Immune Response97▲ 5.2×19 topics
- Immunity91▲ 6.9×11 topics
- Biomarkers87▲ 3.8×15 topics
- Chemotherapy87▲ 3.8×23 topics
- Monoclonal Antibodies86▲ 30×3 topics
- Immunotherapy86▲ 3.7×19 topics
- Respiratory Infections76▲ 21×3 topics
- Vaccination75▲ 30×2 topics
- Community-Acquired Pneumonia74▲ 65×1 topic
- Pneumococcal Conjugate Vaccine74▲ 65×1 topic
- Pharmacokinetics72▲ 8.2×9 topics
- Mutation70▲ 12×5 topics
- Medicinal Chemistry69▲ 7.9×11 topics
- Breast Cancer66▲ 8.1×10 topics
- Coronavirus60▲ 9.2×3 topics
- Economic Evaluation60▲ 16×2 topics
- Cost-effectiveness Analysis58▲ 23×1 topic
- Health Utility Measures58▲ 23×1 topic
- Biopharmaceuticals57▲ 34×3 topics
- Immunogenicity56▲ 40×3 topics
- Viral Transmission56▲ 12×3 topics
- Therapeutic Antibodies54▲ 24×2 topics
- antibody53▲ 17×1 topic
- spike protein53▲ 17×1 topic
Which research topics does Pfizer (United States) publish most on?
By volume in 2022-now: Respiratory viral infections research, Pneumonia and Respiratory Infections, Health Systems, Economic Evaluations, Quality of Life and SARS-CoV-2 and COVID-19 Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Respiratory viral infections research Epidemiology 111 works
- 2 Pneumonia and Respiratory Infections Epidemiology 74 works
- 3 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 58 works
- 4 SARS-CoV-2 and COVID-19 Research Infectious Diseases 53 works
- 5 COVID-19 Clinical Research Studies Infectious Diseases 44 works
- 6 Vaccine Coverage and Hesitancy Health 41 works
- 7 Computational Drug Discovery Methods Computational Theory and Mathematics 39 works
- 8 Statistical Methods in Clinical Trials Statistics and Probability 34 works
- 9 Biosimilars and Bioanalytical Methods Immunology 33 works
- 10 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 32 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Pfizer (United States)'s research output changed?
Output in 2022-2025 was 14% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Pfizer (United States) as a percentage of every work published that year, 0.014% in 2024.
Fractional works of Pfizer (United States) over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year, against all institutions in the same year.
Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 19.4% in 1990.
Other research institutions in New York
- Columbia University
- New York University
- City University of New York
- Mount Sinai Health System
- Memorial Sloan Kettering Cancer Center
- Human Growth Foundation
- Rockefeller University
- Fordham University
Compare Pfizer (United States) with
- vs
Chang'an University
- vs
Chinese Institute for Brain Research
- vs
University of Central Florida
- vs
Indian Institute of Technology Kanpur
- vs
Carl von Ossietzky Universität Oldenburg
- vs
University of Stavanger
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Questions people ask
What does Pfizer publish research on?
In research, Pfizer (United States) stands highest in Health Sciences (#315 of 9,902 worldwide), Medicine (#314 of 8,541 worldwide) and Life Sciences (#574 of 6,403 worldwide), 2022-now. Relative to its size it is most specialised in Applied Microbiology and Biotechnology, Statistics and Probability and Hematology (Applied Microbiology and Biotechnology is 12.9× its share of world research).
Discussion
Ask a question or share a note about Pfizer (United States). Posts are plain text and can be reported.
